You are viewing liveonearth

Previous Entry | Next Entry

Lenticular Cloud
NEW RESEARCH FROM the Annals of the New York Academy of Sciences
1: Ann N Y Acad Sci. 2009 Sep;1173:757-65.
Waterhouse JC, Perez TH, Albert PJ.
Autoimmunity Research Foundation, Thousand Oaks, California 91360, USA. jcw@autoimmunityresearch.org

ABSTRACT
Vitamin D research is discussed in light of the hypothesis that the lower average levels of vitamin D frequently observed in autoimmune disease are not a sign of deficiency. Instead, it is proposed that the lower levels result from chronic infection with intracellular bacteria that dysregulate vitamin D metabolism by causing vitamin D receptor (VDR) dysfunction within phagocytes. The VDR dysfunction causes a decline in innate immune function that causes susceptibility to additional infections that contribute to disease progression. Evidence has been accumulating that indicates that a number of autoimmune diseases can be reversed by gradually restoring VDR function with the VDR agonist olmesartan and subinhibitory dosages of certain bacteriostatic antibiotics. Diseases showing favorable responses to treatment so far include systemic lupus erythematosis, rheumatoid arthritis, scleroderma, sarcoidosis, Sjogren's syndrome, autoimmune thyroid disease, psoriasis, ankylosing spondylitis, Reiter's syndrome, type I and II diabetes mellitus, and uveitis. Disease reversal using this approach requires limitation of vitamin D in order to avoid contributing to dysfunction of nuclear receptors and subsequent negative consequences for immune and endocrine function. Immunopathological reactions accompanying bacterial cell death require a gradual elimination of pathogens over several years. Practical and theoretical implications are discussed, along with the compatibility of this model with current research.

PMID: 19758226 [PubMed - in process]

My question: which intracellular microbes????

SOURCE
http://www.ncbi.nlm.nih.gov/pubmed/19758226?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum

also see
Dr. Trevor Marshall and The Marshall Protocol
uses ABX to get vit D receptors working-->better Th1 response
http://www.marshallprotocol.com

Profile

moon
liveonearth
liveonearth

Latest Month

October 2014
S M T W T F S
   1234
567891011
12131415161718
19202122232425
262728293031 

Tags

Powered by LiveJournal.com
Designed by Naoto Kishi